Liu; Donglin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Liu; Donglin.The latest application filed is for "disease therapy with chimeric antigen receptor (car) constructs and t cells (car-t) or nk cells (car-nk) expressing car constructs".

Company Profile

0.5.12

Liu; Donglin - Kendall Park NJ
LIU; Donglin - Suzhou CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Interferon lambda-antibody complexes Grant 10,022,427 - Chang , et al. July 17, 2	2018-07-17
Disease Therapy With Chimeric Antigen Receptor (car) Constructs And T Cells (car-t) Or Nk Cells (car-nk) Expressing Car Constructs App 20160361360 - Chang; Chien-Hsing ; et al.	2016-12-15
Antibodies Reactive With An Epitope Located In The N-terminal Region Of Muc5ac Comprising Cysteine-rich Subdomain 2 (cys2) App 20160347857 - Liu; Donglin ; et al.	2016-12-01
Antibodies reactive with an epitope located in the N-terminal region of MUC5AC comprising cysteine-rich subdomain 2 (Cys2) Grant 9,452,228 - Liu , et al. September 27, 2	2016-09-27
Non Quenched And Tempered Steel And Manufacturing Process Thereof App 20160230247 - LIU; Donglin ; et al.	2016-08-11
Non Quenched And Tempered Steel And Manufacturing Process Thereof App 20160215358 - LIU; Donglin ; et al.	2016-07-28
Non Quenched And Tempered Steel And Manufacturing Process Thereof App 20160208358 - LIU; Donglin ; et al.	2016-07-21
Non Quenched And Tempered Steel And Manufacturing Process Thereof App 20160208356 - LIU; Donglin ; et al.	2016-07-21
Interferon Lambda-antibody Complexes App 20160129086 - Chang; Chien-Hsing ; et al.	2016-05-12
Anti-mucin Antibodies For Early Detection And Treatment Of Pancreatic Cancer App 20160090413 - Liu; Donglin ; et al.	2016-03-31
Interferon lambada-antibody complexes Grant 9,272,029 - Chang , et al. March 1, 2	2016-03-01
Anti-mucin antibodies for early detection and treatment of pancreatic cancer Grant 9,238,084 - Liu , et al. January 19, 2	2016-01-19
Antibodies Reactive With An Epitope Located In The N-terminal Region Of Muc5ac Comprising Cysteine-rich Subdomain 2 (cys2) App 20150315289 - Liu; Donglin ; et al.	2015-11-05
Anti-mucin Antibodies For Early Detection And Treatment Of Pancreatic Cancer App 20150165076 - Liu; Donglin ; et al.	2015-06-18
Anti-mucin antibodies for early detection and treatment of pancreatic cancer Grant 9,005,613 - Liu , et al. April 14, 2	2015-04-14
Anti-mucin Antibodies For Early Detection And Treatment Of Pancreatic Cancer App 20140227179 - Liu; Donglin ; et al.	2014-08-14
Targeting Interferon-lambda With Antibodies Potently Enhances Anti-tumor And Anti-viral Activities App 20130136718 - Chang; Chien-Hsing ; et al.	2013-05-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.